Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21459735 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients
Condition: Schizophrenia
Interventions: Behavioral: Diet support group;   Behavioral: Group counseling and exercise

Study has passed its completion date and status has not been verified in more than two years.